DARA BioSciences, Inc.

DARA BioSciences, Inc.

DARA BioSciences, Inc. (DARA), formerly Point therapeutics, Inc. is a development stage pharmaceutical company that acquires therapeutic molecules and medical technologies from third parties, and advances their clinical development for later sale to pharmaceutical and biotechnology companies. DARA focuses on two drug development programs: KRN5500 for neuropathic pain in cancer patients and DB959 for type 2 diabetes. On February 12, 2008, Point and DARA BioSciences, Inc. completed their merger transaction, in which DP Acquisition Corp. (a wholly owned subsidiary of Point) merged with and into DARA BioSciences, Inc.

Contact Details

Office Address

DARA BioSciences, Inc.
8601 Six Forks Road, Suite 160
Raleigh, NC, USA 27615
Phone: (919) 872-5578
Fax: (919) 861-0239

Executives

Chairman & Chief Exec. Officer

Dr. Richard A. Franco Sr.

Consultant

Mr. John C. Thomas Jr.

Business Reviews for DARA BioSciences, Inc.

Related Companies